Trial record 4 of 123 for:
Open Studies | "Bone Density"
Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)
The recruitment status of this study is unknown because the information has not been verified recently.
Verified January 2009 by Sheba Medical Center.
Recruitment status was Not yet recruiting
Information provided by:
Sheba Medical Center
First received: January 7, 2009
Last updated: NA
Last verified: January 2009
History: No changes posted
SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not yet evaluated.
||Observational Model: Case Control
Time Perspective: Prospective
Primary Outcome Measures:
- bone density [ Time Frame: 1 month ] [ Designated as safety issue: No ]
- bone density [ Time Frame: 2 years ] [ Designated as safety issue: No ]
| Estimated Enrollment:
| Study Start Date:
| Estimated Primary Completion Date:
||January 2011 (Final data collection date for primary outcome measure)
|Ages Eligible for Study:
||up to 7 Days
|Genders Eligible for Study:
|Accepts Healthy Volunteers:
Healthy term newborn infants to mothers treated with SSRI and healthy controls. bone density mesurment will be applied on the 1-7 days of life.
- Term newborn infants to mothers treated with SSRI and healthy controls
- Preterms, major congenital malformations.
No Contacts or Locations Provided
No publications provided
||Dr.Ayala Maayan, sheba medical center
History of Changes
|Other Study ID Numbers:
|Study First Received:
||January 7, 2009
||January 7, 2009
||Israel: Israeli Health Ministry Pharmaceutical Administration
Keywords provided by Sheba Medical Center:
Additional relevant MeSH terms:
ClinicalTrials.gov processed this record on March 06, 2014
Serotonin Uptake Inhibitors
Neurotransmitter Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Physiological Effects of Drugs